CAS: 202189-81-9 - 2-[1-[2-[4-[1-(4,5-Dihydro-4,4-dimethyl-2-oxazolyl)-1-methylethyl]phenyl]ethyl]-4-piperidinyl]-1H-benzimidazole
Fórmula:C28H36N4O
InChI:InChI=1S/C28H36N4O/c1-27(2)19-33-26(31-27)28(3,4)22-11-9-20(10-12-22)13-16-32-17-14-21(15-18-32)25-29-23-7-5-6-8-24(23)30-25/h5-12,21H,13-19H2,1-4H3,(H,29,30)
Clave InChI:InChIKey=AGKQHLKOMIVKIV-UHFFFAOYSA-N
SMILES:N=1C=2C=CC=CC2NC1C3CCN(CCC4=CC=C(C=C4)C(C5=NC(C)(C)CO5)(C)C)CC3
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Bilastine Impurity 22 REF: 4Z-B-1730CAS: 202189-81-9 | - - - | A consultar | Mar 10 Dic 24 | |
2-Desetoxyethyl-4,5-Dihydrooxazole Bilastine REF: TR-D202180CAS: 202189-81-9 | - - - | 5.351,00 € | Mié 15 Ene 25 | |
2-Desetoxyethyl-4,5-dihydrooxazole bilastine REF: 3D-CIA18981CAS: 202189-81-9 | Min. 95% | - - - | Producto descatalogado |
Ref: 4Z-B-1730
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
2-Desetoxyethyl-4,5-Dihydrooxazole Bilastine
Producto controladoRef: TR-D202180
500mg | 5.351,00 € |
2-Desetoxyethyl-4,5-dihydrooxazole bilastine
Ref: 3D-CIA18981
5mg | Descatalogado | Solicitar información | |
10mg | Descatalogado | Solicitar información | |
25mg | Descatalogado | Solicitar información | |
50mg | Descatalogado | Solicitar información | |
100mg | Descatalogado | Solicitar información |